Cas:472-11-7 Ruscogenin manufacturer & supplier

We serve Chemical Name:Ruscogenin CAS:472-11-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ruscogenin

Chemical Name:Ruscogenin
CAS.NO:472-11-7
Synonyms:(1β,3β,25R)-Spirost-5-ene-1,3-diol;25D-Spirost-5-ene-1|A,3|A-diol;(25R)-Spirost-5-ene-1b,3b-diol;(25R)-Spirost-5-ene-1β,3β-diol;(1β,3β,25R)-Spirost-5-en-1,3-diol;Spirost-5-en-1,3-diol, (1β,3β,25R)-
Molecular Formula:C27H42O4
Molecular Weight:430.62
HS Code:29389090

Physical and Chemical Properties:
Melting point:198-202ºC
Boiling point:563.1±50.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.577
PSA:58.92000
Exact Mass:430.308319
LogP:4.29

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like (1β,3β,25R)-Spirost-5-ene-1,3-diol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Spirost-5-en-1,3-diol, (1β,3β,25R)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1β,3β,25R)-Spirost-5-en-1,3-diol Use and application,(1β,3β,25R)-Spirost-5-ene-1,3-diol technical grade,usp/ep/jp grade.


Related News: With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand. Ruscogenin manufacturer The company reported that it was cooperating with the Justice Department probe and that an outside law firm was also “investigating these allegations thoroughly.” Ruscogenin supplier Today’s decisions represent progress in our continued efforts to make a difference in this pandemic on a global scale, Kathy Wengel, J&J’s chief global supply chain officer, said in the statement. Ruscogenin vendor With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand. Ruscogenin factory The company reported that it was cooperating with the Justice Department probe and that an outside law firm was also “investigating these allegations thoroughly.”